Investment Pitches

Pitch Summary:
Our one new buy was also a sell this quarter. Initially identified through a screening for undervalued SPACs, Pagaya Technologies (PGY) piqued our interest with its innovative white-label product technology platform, utilizing advanced data science and AI to enhance loan origination for financial institutions and to offer attractive asset-backed securities (ABS) or private credit securities for investors. A key differentiator for PGY was its asset-light business model, predicated on raising capital from investors before proceeding with the securitization of loans sourced from its financial partners. The company's earnings call in the first quarter, coupled with positive guidance for 2024, seemed to mitigate previously identified risks, illustrating a path forward for sustained growth. However, regulatory requirements necessitate PGY to retain a 5% stake in the ABS on its balance sheet, introducing a need for an external funding source. This requirement contrasts with traditional banking operations, which fund loan originations through customer deposits at significantly lower costs. Our initial belief was that PGY would navigate this challenge by establishing an offtake agreement to manage the 5% capital requirement efficiently. Regrettably, subsequent developments did not align with our expectations. Shortly after our discussions with PGY, the company initiated capital raise, diverging from the strategy outlined in our prior conversations. This move raised concerns about the transparency and strategic direction of PGY, prompting us to reevaluate our position. Faced with the potential misalignment of PGY's business model and the strategic implications of utilizing equity as a primary funding source—arguably the most costly approach—we decided to divest our stake. This decision underscores our commitment to maintaining a portfolio built on trust, strategic coherence, and clear communication, principles we found compromised in this instance.

BSD Analysis:
The manager initially invested in Pagaya Technologies based on its innovative AI-driven lending platform and asset-light business model that appeared to offer scalable growth potential. The investment thesis centered on PGY's ability to enhance loan origination for financial institutions while providing attractive asset-backed securities to investors. However, the manager quickly reversed course due to regulatory requirements forcing PGY to retain 5% stakes in ABS on its balance sheet, creating funding challenges. The critical issue emerged when management diverged from previously discussed strategies by initiating an unexpected capital raise, raising red flags about transparency and strategic direction. The manager viewed equity financing as the most expensive funding option, fundamentally misaligning with the original asset-light thesis. This rapid buy-and-sell decision reflects the manager's disciplined approach to maintaining portfolio quality and strategic coherence. The exit underscores concerns about management credibility and the viability of PGY's business model under current regulatory constraints.

Pitch Summary:
Lastly, global dental manufacturing company, Envista Holdings Corp. (NVST), declined on mixed earnings results and disappointing full year guidance implying a step-down in profitability. The company is navigating heightened investments, sanctions in Russia and pricing pressures in China due to volume-based procurement (VBP) reimbursement, as well as a weakening environment in North America for large dental equipment and implants. Meanwhile, NVST is in search of a new CEO and CFO creating another business distraction and further uncertainty. Shares are likely range bound for the next couple of quarters until a new leadership team is installed and NVST works through its challenges. We are deeply disappointed with this investment. After reassessing the name, we have concluded that the company has multiple opportunities to drive upside over the long-term. We believe NVST will benefit from its rich research and development pipeline, several new products in high-growth dental segments, facility consolidation and previous IT investments. At current levels, we believe the downside is priced in. We are now evaluating the upside return potential with shares trading at a significant discount to our estimate of private market value.

BSD Analysis:
Ariel expresses deep disappointment with Envista Holdings while maintaining a cautiously optimistic long-term view. The fund acknowledges significant near-term challenges including mixed earnings, disappointing guidance, Russian sanctions, Chinese pricing pressures from volume-based procurement, and a weakening North American dental equipment market. Leadership uncertainty with searches for new CEO and CFO positions adds further complexity and potential range-bound performance. However, after reassessment, Ariel identifies multiple long-term value drivers including a robust R&D pipeline, new products in high-growth dental segments, facility consolidation benefits, and previous IT investments. The fund believes current share prices reflect the downside risks while trading at a significant discount to private market value, suggesting potential upside as challenges resolve and new leadership executes on the company's opportunities.

Pitch Summary:
Shares of global leader in for-profit education, Adtalem Global Education (ATGE), tumbled when the publication of a short report accusing the company of being at risk of losing some federal funding was picked up by a major news outlet. Management moved up its earnings release to publicly address the "inaccuracies and misleading conclusions," noting there is "no existential threat" to the business or federal funding. Meanwhile, the fundamentals of the business remain robust, underscored by a top-and bottom-line earnings beat, significant margin expansion and an acceleration in new student enrollment growth. As the number one grantor of nursing degrees in the U.S. and the largest producer of African American MDs, PhDs and nurses in the country, we remain confident ATGE will benefit from the healthcare worker shortage in the U.S.

BSD Analysis:
Ariel maintains strong conviction in Adtalem Global Education despite short-seller attacks and temporary share price weakness. The fund dismisses the short report as containing inaccuracies and misleading conclusions, noting management's swift response and assurance of no existential threat to federal funding. Ariel emphasizes robust underlying fundamentals including top and bottom-line earnings beats, significant margin expansion, and accelerating new student enrollment growth. The investment thesis is anchored on ATGE's market-leading position as the top grantor of nursing degrees in the U.S. and largest producer of African American healthcare professionals. Given the persistent healthcare worker shortage in America, Ariel believes ATGE is uniquely positioned to benefit from strong structural demand for healthcare education and training programs.

Pitch Summary:
By comparison, entertainment company, Paramount Global (PARA), traded lower in the quarter as linear Pay TV pressures including shifts in viewership, subscriber erosion, softer ad revenues and continued losses in its streaming business presented headwinds. Despite the negative price action, management expects the consolidated company to deliver significant earnings growth in 2024 and reach Paramount+ domestic profitability in 2025. Meanwhile, PARA remains laser focused on optimizing its cost base while improving monetization for its streaming business, which should drive free cash flow in 2024 and beyond. After many calls with management we have a high degree of confidence that the value of Paramount's proprietary content remains meaningfully underappreciated at current trading levels. However, recent rumors regarding merger talks that forego competitive bidding in favor of an exclusive discussion with Skydance, where the control premium would differentiate the financial position of a single shareholder over all other shareholders is averse to the fair market value of the company. This action along with a new proposal for changes at the board level have heightened our concerns around the company's ability to act on behalf of all shareholders.

BSD Analysis:
Ariel maintains a bullish fundamental view on Paramount Global despite near-term headwinds and governance concerns. The fund acknowledges significant challenges including linear TV pressures, subscriber erosion, and streaming losses, but emphasizes management's guidance for significant 2024 earnings growth and Paramount+ domestic profitability by 2025. Ariel highlights the company's focus on cost optimization and streaming monetization improvements that should drive free cash flow generation. The investment thesis centers on the underappreciated value of Paramount's proprietary content library, supported by extensive management discussions. However, Ariel expresses serious concerns about potential merger discussions with Skydance that could favor a single shareholder over others, along with proposed board changes that raise questions about management's commitment to all shareholders' interests.

Pitch Summary:
Additionally, Madison Square Garden Entertainment Corp. (MSGE), shares advanced in the quarter following a robust earnings beat, driven by an increase in the number of concerts held at MSGE's venues, strong demand for the Christmas Spectacular and higher per-event revenues. Notably, management raised full year 2024 guidance and reiterated its outlook to achieve a low-double-digit percentage increase in event bookings. With marquee assets such as New York's Madison Square Garden, Radio City Music Hall, Beacon Theatre and The Chicago Theater, we believe MSGE is well positioned to capitalize on strong demand for live entertainment. In our view, MSGE's assets generate stable cash flow that should enable deleveraging. At current levels, the company is trading at a significant discount to our estimate of private market value.

BSD Analysis:
Ariel presents a strong bull case for Madison Square Garden Entertainment based on operational momentum and asset quality. The fund highlights robust quarterly earnings driven by increased concert activity, strong Christmas Spectacular demand, and higher per-event revenues, leading management to raise 2024 guidance with expectations for low-double-digit event booking growth. MSGE's portfolio of iconic venues including Madison Square Garden, Radio City Music Hall, Beacon Theatre, and The Chicago Theater provides significant competitive advantages in the live entertainment market. The company's stable cash flow generation from these premium assets positions it well for deleveraging while capitalizing on strong live entertainment demand. Ariel views the stock as significantly undervalued relative to their private market value estimate, offering compelling upside potential.

Pitch Summary:
Manufacturer and distributor of floorcovering products, Mohawk Industries Inc. (MHK) also increased during the quarter. Although consumer demand and pricing remains muted due to a challenging macro backdrop, cost savings and productivity initiatives, along with lower input costs more than offset these difficulties. In our view, MHK's healthy balance sheet and success managing through economic cycles position the company to benefit from long-term growth in residential remodeling, new home construction and commercial projects. At current levels, MHK is trading at a compelling discount to our estimate of private market value.

BSD Analysis:
Ariel maintains a bullish stance on Mohawk Industries despite near-term headwinds from muted consumer demand and pricing pressures. The fund emphasizes management's effective cost control through savings initiatives and productivity improvements, which have more than offset challenging market conditions and benefited from lower input costs. Ariel highlights the company's strong balance sheet and proven track record of navigating economic cycles as key competitive advantages. The investment thesis centers on Mohawk's positioning to capitalize on long-term secular growth drivers including residential remodeling, new home construction, and commercial development projects. At current trading levels, Ariel believes the stock represents compelling value, trading at a significant discount to their private market valuation estimate.

Pitch Summary:
Some holdings in the portfolio advanced considerably this quarter. Shares of live entertainment, media and technology company, Sphere Entertainment Co. (SPHR) jumped during the period. SPHR's first full quarter of operating results were robust. Revenue and margins beat expectations driven by the strong performance of the Sphere's experience show, Postcard from Earth, sellout crowds at the U2 concerts and a highly profitable takeover of the Sphere by F1. Additionally, events such as the Consumer Electronics Show and Super Bowl in Las Vegas, are expected to aid advertising and sponsorship revenues from the Exosphere (the Sphere's exterior). Meanwhile, the CEO purchased a significant number of shares, underscoring his confidence in the company as well as its ability to secure global franchise partners for future Sphere models. Although the Las Vegas venue will take some time to reach its full potential, the company is well on its way to having events 365 days a year including concert residencies, marquee sporting and corporate events, and Sphere Experience exhibits. In our view, the Sphere's new experiential immersive venue and the company's two regional sports and entertainment networks present a long-term opportunity, which remains meaningfully underappreciated at current trading levels.

BSD Analysis:
Ariel presents a compelling bull case for Sphere Entertainment based on strong operational momentum and undervaluation. The fund highlights robust first-quarter results with revenue and margins beating expectations, driven by successful shows like Postcard from Earth and U2 concerts, plus profitable F1 events. Management confidence is evidenced by significant CEO share purchases and the company's progress toward year-round venue utilization. The Las Vegas Sphere's unique immersive technology creates a differentiated entertainment experience with multiple revenue streams including concerts, corporate events, and advertising from the exterior Exosphere. Ariel views the combination of the innovative Sphere venue and regional sports networks as creating long-term value that remains significantly underappreciated by the market at current trading levels.

Pitch Summary:
Also in the quarter, we initiated a new position in manufacturer and developer of laboratory equipment and biological testing, Bio-Rad Laboratories Inc. (BIO). The company offers a worldwide presence with the United States representing 42% of revenue, Europe 31%, Asia 21% and Other 6%. Its customer base is diversified with hospital labs representing 34% of revenue, reference labs 11%, transfusion labs 10%, academic 21%, biopharma 15%, and applied markets 9%. BIO boasts a solid financial profile, rising operating margins, high and recurring revenue streams. We believe Bio-Rad is a classic Ariel company, offering leading innovative products in a growing worldwide marketplace. The company estimates 80% of sales are from products in which Bio-Rad has dominant market share.

BSD Analysis:
Ariel initiated a new position in Bio-Rad Laboratories, viewing it as a classic Ariel investment opportunity with strong competitive positioning and financial characteristics. The company demonstrates impressive global diversification with balanced revenue exposure across the US (42%), Europe (31%), and Asia (21%), reducing geographic concentration risk. The customer base is well-diversified across hospital labs, reference labs, academic institutions, biopharma companies, and applied markets, providing stability and multiple growth avenues. Bio-Rad's financial profile is compelling with rising operating margins and high recurring revenue streams, indicating strong operational execution and customer loyalty. The investment thesis centers on the company's dominant market positions, with an estimated 80% of sales coming from products where Bio-Rad holds leading market share. Ariel believes the company offers leading innovative products in a growing worldwide marketplace, positioning it well to capitalize on expanding demand for laboratory equipment and biological testing solutions.

Pitch Summary:
Lastly, global dental manufacturing company, Envista Holdings Corp. (NVST), declined on mixed earnings results and disappointing full year guidance implying a step-down in profitability. The company is navigating heightened investments, sanctions in Russia and pricing pressures in China due to volume-based procurement (VBP) reimbursement, as well as a weakening environment in North America for large dental equipment and implants. Meanwhile, NVST is in search of a new CEO and CFO creating another business distraction and further uncertainty. Shares are likely range bound for the next couple of quarters until a new leadership team is installed and NVST works through its challenges. We are deeply disappointed with this investment. After reassessing the name, we have concluded that the company has multiple opportunities to drive upside over the long-term. We believe NVST will benefit from its rich research and development pipeline, several new products in high-growth dental segments, facility consolidation and previous IT investments. At current levels, we believe the downside is priced in. We are now evaluating the upside return potential with shares trading at a significant discount to our estimate of private market value.

BSD Analysis:
Despite expressing deep disappointment with recent performance, Ariel maintains a long-term bullish stance on Envista Holdings following a comprehensive reassessment. The company faces significant near-term challenges including mixed earnings, disappointing guidance, heightened investments, Russian sanctions, Chinese pricing pressures, and leadership transitions with new CEO and CFO searches. However, the fund believes these headwinds have created an attractive entry point with downside risks largely priced in. The investment thesis focuses on multiple long-term value drivers including a rich R&D pipeline, new products in high-growth dental segments, facility consolidation benefits, and previous IT investments that should drive operational efficiency. Ariel expects shares to remain range-bound until new leadership is installed and operational challenges are addressed. The fund views current valuation levels as compelling, with shares trading at a significant discount to private market value, suggesting substantial upside potential as the company navigates through its current difficulties and capitalizes on its long-term opportunities.

Pitch Summary:
Leading provider of audio components and precision electrical devices, Knowles Corporation (KN), also traded lower on mixed earnings results. Strength within their core hearing health market was offset by weaker demand for precision devices from Industrial clients. However, management is focused on cost controls and inventory management which should help drive meaningful earnings growth this year. Longer-term, we believe KN will benefit from further focusing its business on its niche and market leading positions in hearing health and precision devices, and away from the more competitive consumer electronics market. Additionally, we are optimistic in the synergy opportunities driven by the recent acquisition of Cornell Dubilier, which has enhanced KN's existing customer base and revenue streams. At current levels, KN is trading at a meaningful discount to our estimate of private market value.

BSD Analysis:
Ariel maintains a bullish long-term view on Knowles Corporation despite recent mixed earnings results and near-term headwinds. While the company experienced weakness in precision devices from industrial clients, strength in the core hearing health market demonstrates the resilience of their market-leading positions. Management's focus on cost controls and inventory management should drive meaningful earnings growth in the current year, providing operational leverage. The investment thesis centers on the company's strategic refocusing toward niche, market-leading positions in hearing health and precision devices while moving away from the more competitive consumer electronics market. The recent acquisition of Cornell Dubilier enhances the investment case by expanding the customer base and revenue streams, creating synergy opportunities. Ariel views current valuation levels as attractive, with shares trading at a meaningful discount to private market value estimates, suggesting significant upside potential as the strategic repositioning gains traction.

Pitch Summary:
Alternatively, several positions weighed on performance. Shares of retail drugstore operator, Walgreens Boots Alliance, Inc. (WBA), declined over the period as challenging consumer and macroeconomic conditions, ongoing operational issues and a significant cut in the dividend weighed on shares. To address these performance lows, WBA's new CEO is rebuilding the company's management team with leaders who have significant experience in healthcare services. Meanwhile, WBA continues to execute on its cost savings initiatives to optimize profitability and is using excess capital to prioritize the sustainability of its operations and balance sheet. Over the medium-term, we expect a re-rating in shares as the new executive team earns credibility, margins and free cash flow show signs of improvement and the company deleverages. WBA shares are currently trading at a significant discount to our estimate of private market value.

BSD Analysis:
Despite recent underperformance, Ariel maintains a constructive medium-term outlook for Walgreens Boots Alliance based on management changes and operational improvements. The company faces near-term headwinds including challenging consumer conditions, operational issues, and dividend cuts that have pressured shares. However, the fund sees potential catalysts emerging through the new CEO's efforts to rebuild the management team with experienced healthcare services leaders. Ariel believes the company's ongoing cost savings initiatives and focus on operational sustainability will drive margin improvement and free cash flow generation over time. The investment thesis relies on a management-driven turnaround story, expecting a re-rating as the new executive team establishes credibility and delivers operational improvements. The fund views current valuation levels as attractive, with shares trading at a significant discount to private market value, suggesting meaningful upside potential as the transformation progresses.

Pitch Summary:
Additionally, Madison Square Garden Entertainment Corp. (MSGE), shares advanced in the quarter following a robust earnings beat, driven by an increase in the number of concerts held at MSGE's venues, strong demand for the Christmas Spectacular and higher per-event revenues. Notably, management raised full year 2024 guidance and reiterated its outlook to achieve a low-double-digit percentage increase in event bookings. With marquee assets such as New York's Madison Square Garden, Radio City Music Hall, Beacon Theatre and The Chicago Theater, we believe MSGE is well positioned to capitalize on strong demand for live entertainment. In our view, MSGE's assets generate stable cash flow that should enable deleveraging. At current levels, the company is trading at a significant discount to our estimate of private market value.

BSD Analysis:
Ariel presents a strong bull case for Madison Square Garden Entertainment based on operational momentum and premium asset portfolio. The company delivered a robust earnings beat driven by increased concert activity, strong demand for signature events like the Christmas Spectacular, and higher per-event revenues, demonstrating effective venue utilization and pricing power. Management's raised 2024 guidance and outlook for low-double-digit growth in event bookings reflects confidence in sustained demand recovery. The investment thesis centers on MSGE's marquee venue portfolio, including iconic properties like Madison Square Garden, Radio City Music Hall, Beacon Theatre, and The Chicago Theater, which provide competitive advantages in the live entertainment market. Ariel believes these premium assets generate stable cash flows that support deleveraging efforts while capitalizing on strong demand for live entertainment experiences. The fund views current valuation levels as attractive, trading at a significant discount to private market value estimates.

Pitch Summary:
Financial advisory and asset manager, Lazard Ltd. (LAZ) also increased in the period following solid top- and bottom-line results, highlighted by momentum in the advisory business, improving financing markets and early signs of progress on previously articulated cost-savings initiatives. Near-term, management reiterated its cautiously optimistic long-term guidance for the mergers & acquisitions segment given an improving macroeconomic outlook, although LAZ expects geopolitical uncertainty to remain a headwind. Notably, the company aims to increase firm-wide revenue two-fold through double-digit annual revenue growth by 2030. At current levels, we believe the LAZ represents a healthy discount to our private market value estimate.

BSD Analysis:
Ariel maintains a bullish stance on Lazard based on improving operational metrics and ambitious growth targets. The company delivered solid financial results with momentum building in the advisory business, supported by improving financing markets and early progress on cost-saving initiatives. Management's cautiously optimistic outlook for the M&A segment reflects confidence in the improving macroeconomic environment, though they acknowledge geopolitical uncertainty as a persistent headwind. The most compelling aspect of the investment case is management's ambitious target to double firm-wide revenue through double-digit annual growth by 2030, suggesting significant expansion potential. Ariel views the current valuation as attractive, believing shares trade at a healthy discount to private market value. The combination of operational improvements, favorable market conditions, and aggressive growth targets supports the fund's positive outlook for this financial advisory and asset management firm.

Pitch Summary:
Shares of global leader in electrical protection and connection solutions, nVent Electric plc (NVT) jumped following strong quarterly earnings results, highlighted by healthy organic revenue growth, margin expansion and robust free cash flow generation. Management also provided a solid full year outlook for 2024, as NVT continues to execute on its global strategy, which is focused on high-growth verticals, new products and innovation. We expect NVT to continue to benefit from secular trends towards increased electrification and data center development, as well as from internal operational improvements.

BSD Analysis:
Ariel presents a compelling bull case for nVent Electric based on strong operational execution and favorable secular trends. The company delivered impressive quarterly results with healthy organic revenue growth, margin expansion, and robust free cash flow generation, demonstrating effective operational management. Management's solid 2024 outlook reinforces confidence in the company's strategic direction focused on high-growth verticals and innovation. The investment thesis is anchored on two key secular tailwinds: increased electrification trends and data center development, both of which should drive sustained demand for nVent's electrical protection and connection solutions. The combination of internal operational improvements and external market dynamics positions the company well for continued growth. The fund's confidence is supported by management's proven ability to execute on their global strategy while capitalizing on emerging market opportunities in the electrical infrastructure space.

Pitch Summary:
We also bought leading German multinational technology conglomerate, Siemens AG. The company's operations encompass automation for manufacturing and processing, smart infrastructure, energy systems, rail technology, and digital healthcare solutions. Although shares have historically been undervalued due to concerns over the complexity of its disparate portfolio of businesses across sectors, we have identified several factors conducive to a potential re-rating. Over the last five years, Siemens has simplified its portfolio into high-quality businesses benefitting from secular growth themes such as energy transition, digitalization and industrial automation. Additionally, the new, shareholder-friendly management team is focused on enhancing free cash flow generation and improving capital allocation, which we view as a key catalyst benefitting the stock longer-term.

BSD Analysis:
Ariel initiated a position in Siemens, viewing the German conglomerate as undervalued due to portfolio complexity concerns. The company's diversified operations span automation, smart infrastructure, energy systems, rail technology, and digital healthcare solutions. Over the past five years, management has simplified the portfolio, focusing on high-quality businesses aligned with secular growth themes including energy transition, digitalization, and industrial automation. The new shareholder-friendly management team prioritizes free cash flow generation and improved capital allocation as key value drivers. Ariel sees these operational improvements as catalysts for a potential re-rating of the stock. The combination of portfolio simplification, exposure to secular growth trends, and enhanced capital discipline positions Siemens for sustained outperformance. The market appears to undervalue the company's transformation and strategic positioning.

Pitch Summary:
We purchased China-based technology-driven E-commerce company, JD.com, Inc. The brand has long been known across the region as a superior online shopping channel due to its unique first-party model and unparalleled fulfillment service underpinned by JD Logistics. Yet, a challenging macro environment drove shares lower as shoppers began seeking bargains. In response, the company made significant investments in elevating its third-party merchant platform to enhance its variety of product offerings and price competitiveness for consumers. We believe these actions will yield an improved product mix, stronger top-line growth and margin expansion on a go-forward basis.

BSD Analysis:
Ariel established a position in JD.com, recognizing the company's superior e-commerce platform and logistics capabilities in China. JD's first-party retail model and JD Logistics network have established it as a premium online shopping destination with unmatched fulfillment services. The challenging macro environment created a buying opportunity as price-conscious consumers initially pressured the business. Management's strategic response involved significant investments in the third-party merchant platform to enhance product variety and price competitiveness. Ariel believes these platform improvements will drive an improved product mix and stronger revenue growth. The enhanced marketplace should also support margin expansion over time as the company leverages its logistics infrastructure more efficiently. This positions JD.com to emerge stronger from the current macro headwinds.

Pitch Summary:
We added Aptiv PLC (APTV) which designs and manufactures vehicle components and provides electrical/electronic and active safety technology solutions to the global automotive and commercial vehicle markets. We believe the secular trend of electrification and digitization within the automobile industry, coupled with the expansion of Chinese original equipment manufacturers (OEMs), will accelerate demand and drive long-term growth. Additionally, we anticipate APTV will grow earnings per share over the near-term through its divesture of the autonomous driving joint venture, Motional. In our view, the name is currently trading at a significant discount relative to our estimate of intrinsic value.

BSD Analysis:
Ariel initiated a position in Aptiv, viewing the automotive technology supplier as well-positioned for secular industry trends. The company's focus on electrical/electronic systems and active safety technology aligns with the ongoing electrification and digitization of vehicles. The expansion of Chinese OEMs should accelerate demand for Aptiv's advanced technology solutions globally. A key near-term catalyst is the divestiture of the Motional autonomous driving joint venture, which should boost earnings per share. Ariel believes the market is undervaluing Aptiv's exposure to high-growth automotive technology segments. The combination of secular tailwinds, strategic portfolio optimization, and attractive valuation makes Aptiv an compelling investment in the evolving automotive ecosystem. The company's technology leadership positions it to benefit from the industry's transformation.

Pitch Summary:
Finally, leading electric utility in Spain, Endesa S.A. underperformed in the period. Earnings came in below expectations mainly due to the negative impact of a provision related to a gas contract arbitration. Broad weakness across the gas sector, driven by lower-than-expected consumption and a decline in prices further weighed down shares. Nonetheless, Endesa reiterated its strategic plan through 2026, which includes expectations for higher gas margins, a 70% dividend payout and an optimistic regulatory environment. In our view, Endesa presents a compelling long-term ESG opportunity, as it works toward shuttering coal capacity and moves forward with a multi-billion-euro investment in renewables to reduce greenhouse gas emissions and lower the cost of power generation.

BSD Analysis:
Ariel remains bullish on Endesa despite quarterly underperformance driven by gas contract arbitration provisions and sector weakness. The company reaffirmed its strategic plan through 2026, targeting higher gas margins and maintaining a 70% dividend payout in a favorable regulatory environment. Ariel views Endesa as a compelling ESG investment opportunity given its energy transition strategy. The company is actively shuttering coal capacity while investing billions in renewable energy infrastructure. This transition should reduce greenhouse gas emissions while lowering power generation costs over time. The combination of a strong dividend yield, regulatory support, and leadership in Spain's energy transition positions Endesa as an attractive long-term utility investment. The current weakness appears temporary relative to the company's strategic transformation.

Pitch Summary:
Germany-based kidney dialysis services and products provider, Fresenius Medical Care AG also traded lower in the quarter, despite solid organic sales growth and the delivery of a bottom-line earnings beat. In our view, the new management team is making progress as they expect to generate mid-single digit earnings growth in 2024 and reach their net debt to adjusted EBITDA target range by year end. Even assuming high rates of both uptake and effectiveness of glucagon-like-peptide-1 (GLP-1) drugs, we believe the overall impact on dialysis volumes will be small in the near-to-medium term. We also think the cardio protective effects of the GLP-1 class may enable patients to live longer, thereby increasing the overall size of the end-stage renal disease incidence pool.

BSD Analysis:
Ariel maintains confidence in Fresenius Medical Care despite quarterly underperformance, noting solid organic sales growth and earnings beats. The new management team is executing well with expectations for mid-single digit earnings growth in 2024 and debt reduction targets. A key concern for the dialysis industry is the potential impact of GLP-1 drugs on patient volumes, but Ariel believes this threat is overstated. The fund argues that even with high GLP-1 adoption rates, the near-to-medium term impact on dialysis volumes will be minimal. Importantly, the cardioprotective benefits of GLP-1 drugs may actually extend patient lifespans, potentially increasing the overall pool of end-stage renal disease patients over time. This contrarian view positions Fresenius to benefit from demographic trends while addressing market concerns about competitive threats.

Pitch Summary:
New holding within the portfolio, Japanese video game publisher, Bandai Namco Holding Inc., declined on the announcement of larger than expected game impairments and subsequent downward revision in full year guidance. We think earnings for the digital gaming segment have bottomed and expect the division to return to growth over the next fiscal year given Bandai's healthy pipeline and improved standards for greenlighting new video games. While anime has been highly popular in Japan, Netflix's recent streaming of anime content has expanded its popularity to markets overseas. Bandai is capitalizing on the strong growing demand for the genre through toy and video game sales, a global movie deal as well as the expansion of licensing its intellectual property across merchandise, trading cards and amusement arcades. In our view, the market is currently underappreciating Bandai's diversified growth potential. We see upside in the company's toys and hobby unit and forecast solid free cash flow generation in the years ahead.

BSD Analysis:
Ariel initiated a position in Bandai Namco despite near-term headwinds from game impairments and reduced guidance, viewing the weakness as a buying opportunity. The fund believes digital gaming earnings have bottomed and expects a return to growth next fiscal year driven by an improved pipeline and better project selection standards. The global expansion of anime popularity, accelerated by Netflix streaming, creates significant monetization opportunities across Bandai's diversified business model. The company is well-positioned to capitalize on anime demand through toys, video games, movies, and IP licensing across multiple channels. Ariel sees the market undervaluing Bandai's diversified growth potential beyond gaming. The toys and hobby segment offers additional upside, while the company's strong IP portfolio should generate solid free cash flow over the medium term.